Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #122404 on Biotech Values
genisi
06/27/11 9:19 AM
#122405 RE: genisi #122404
mcbio
06/27/11 9:47 PM
#122465 RE: genisi #122404
Different approaches but all aiming Abeta: Cytos (partner with NVS) has a peptide vaccine in phase II, Transition Therapeutics (partner with Elan) with a scyllo-inositol, NeuroGenetic, EnVivo, and Satori are all in the gamma secretase modulators area and CoMentis (partner with Astellas) has a BACE inhibitor.
DewDiligence
10/17/14 12:22 PM
#182895 RE: genisi #122404